Document is current

Any future updates will be listed below

Prediabetes as an indication for GLP-1 therapy. Clarifying evidence thresholds and clinical guardrails

Crossref DOI link: https://doi.org/10.1038/s41366-025-01959-3

Published Online: 2025-11-15

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark